Role for the M1 Muscarinic Acetylcholine Receptor in Top-Down Cognitive Processing Using a Touchscreen Visual Discrimination Task in Mice

ACS Chemical Neuroscience

Volumn 6, Issue 10, 2015, Pages 1683-1695

  Gould, R W ^a   Dencker, D ^c   Grannan, M ^a   Bubser, M ^a   Zhan, X ^a   Wess, J ^d   Xiang, Z ^a   Locuson, C ^a   Lindsley, C W ^a,b   Conn, P J ^a   Jones, C K ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c Psychiatric Centre Copenhagen   (Denmark)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

BQCA; M1 knockout mice; M1 muscarinic acetylcholine receptors; Positive allosteric modulators; top down processing; touchscreen cognition

Indexed keywords

MUSCARINIC M1 RECEPTOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; MESSENGER RNA; QUINOLONE DERIVATIVE;

ALLOSTERISM; ANIMAL EXPERIMENT; ARTICLE; COGNITION; CONTROLLED STUDY; KNOCKOUT MOUSE; LEARNING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TASK PERFORMANCE; VISUAL DISCRIMINATION; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; COGNITION DISORDERS; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INSTRUMENTAL CONDITIONING; METABOLISM; PATTERN RECOGNITION; PERCEPTIVE DISCRIMINATION; PHOTOSTIMULATION; PHYSIOLOGY; REINFORCEMENT; TOUCH; TRANSGENIC MOUSE;

ANALYSIS OF VARIANCE; ANIMALS; CHOLINERGIC AGENTS; COGNITION DISORDERS; CONDITIONING, OPERANT; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PATTERN RECOGNITION, VISUAL; PHOTIC STIMULATION; QUINOLONES; RECEPTOR, MUSCARINIC M1; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; RNA, MESSENGER; TOUCH;

EID: 84945911386     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/acschemneuro.5b00123     Document Type: Article

References (66)

1. Nuechterlein, K. H., Barch, D. M., Gold, J. M., Goldberg, T. E., Green, M. F., and Heaton, R. K. (2004) Identification of separable cognitive factors in schizophrenia Schizophr Res. 72, 29-39 10.1016/j.schres.2004.09.007
2. (2000) Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Publishing, Washington, DC.
3. Barch, D. M. and Ceaser, A. (2012) Cognition in schizophrenia: core psychological and neural mechanisms Trends Cognit. Sci. 16, 27-34 10.1016/j.tics.2011.11.015
4. Bobes, J., Garcia-Portilla, M. P., Bascaran, M. T., Saiz, P. A., and Bousono, M. (2007) Quality of life in schizophrenic patients Dialogues Clin Neurosci 9, 215-226
5. Green, M. F., Kern, R. S., and Heaton, R. K. (2004) Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS Schizophr Res. 72, 41-51 10.1016/j.schres.2004.09.009
6. Green, M. F. (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatry 153, 321-330 10.1176/ajp.153.3.321
7. Sarter, M., Givens, B., and Bruno, J. P. (2001) The cognitive neuroscience of sustained attention: where top-down meets bottom-up Brain Res. Rev. 35, 146-160 10.1016/S0165-0173(01)00044-3
8. Kastner, S. and Ungerleider, L. G. (2000) Mechanisms of visual attention in the human cortex Annu. Rev. Neurosci. 23, 315-341 10.1146/annurev.neuro.23.1.315
9. Hahn, B., Robinson, B. M., Kaiser, S. T., Harvey, A. N., Beck, V. M., Leonard, C. J., Kappenman, E. S., Luck, S. J., and Gold, J. M. (2010) Failure of schizophrenia patients to overcome salient distractors during working memory encoding Biol. Psychiatry 68, 603-609 10.1016/j.biopsych.2010.04.014
10. Neuhaus, A. H., Karl, C., Hahn, E., Trempler, N. R., Opgen-Rhein, C., Urbanek, C., Hahn, C., Ta, T. M., and Dettling, M. (2011) Dissection of early bottom-up and top-down deficits during visual attention in schizophrenia Clin. Neurophysiol. 122, 90-98 10.1016/j.clinph.2010.06.011
11. Barbalat, G., Chambon, V., Domenech, P. J., Ody, C., Koechlin, E., Franck, N., and Farrer, C. (2011) Impaired hierarchical control within the lateral prefrontal cortex in schizophrenia Biol. Psychiatry 70, 73-80 10.1016/j.biopsych.2011.02.009
12. Cook, J., Barbalat, G., and Blakemore, S. J. (2012) Top-down modulation of the perception of other people in schizophrenia and autism Front. Hum. Neurosci. 6, 175 10.3389/fnhum.2012.00175
13. Luck, S. J., Fuller, R. L., Braun, E. L., Robinson, B., Summerfelt, A., and Gold, J. M. (2006) The speed of visual attention in schizophrenia: electrophysiological and behavioral evidence Schizophr Res. 85, 174-195 10.1016/j.schres.2006.03.040
14. Fuller, R. L., Luck, S. J., Braun, E. L., Robinson, B. M., McMahon, R. P., and Gold, J. M. (2006) Impaired control of visual attention in schizophrenia J. Abnorm Psychol 115, 266-275 10.1037/0021-843X.115.2.266
15. Gold, J. M., Fuller, R. L., Robinson, B. M., Braun, E. L., and Luck, S. J. (2007) Impaired top-down control of visual search in schizophrenia Schizophr Res. 94, 148-155 10.1016/j.schres.2007.04.023
16. Bussey, T. J., Padain, T. L., Skillings, E. A., Winters, B. D., Morton, A. J., and Saksida, L. M. (2008) The touchscreen cognitive testing method for rodents: how to get the best out of your rat Learn. Mem. 15, 516-523 10.1101/lm.987808
17. Mar, A. C., Horner, A. E., Nilsson, S. R., Alsio, J., Kent, B. A., Kim, C. H., Holmes, A., Saksida, L. M., and Bussey, T. J. (2013) The touchscreen operant platform for assessing executive function in rats and mice Nat. Protoc. 8, 1985-2005 10.1038/nprot.2013.123
18. Oomen, C. A., Hvoslef-Eide, M., Heath, C. J., Mar, A. C., Horner, A. E., Bussey, T. J., and Saksida, L. M. (2013) The touchscreen operant platform for testing working memory and pattern separation in rats and mice Nat. Protoc. 8, 2006-2021 10.1038/nprot.2013.124
19. Horner, A. E., Heath, C. J., Hvoslef-Eide, M., Kent, B. A., Kim, C. H., Nilsson, S. R., Alsio, J., Oomen, C. A., Holmes, A., Saksida, L. M., and Bussey, T. J. (2013) The touchscreen operant platform for testing learning and memory in rats and mice Nat. Protoc. 8, 1961-1984 10.1038/nprot.2013.122
20. Dickson, P. E., Corkill, B., McKimm, E., Miller, M. M., Calton, M. A., Goldowitz, D., Blaha, C. D., and Mittleman, G. (2013) Effects of stimulus salience on touchscreen serial reversal learning in a mouse model of fragile X syndrome Behav. Brain Res. 252, 126-135 10.1016/j.bbr.2013.05.060
21. Terry, A. V., Jr. and Buccafusco, J. J. (2003) The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development J. Pharmacol. Exp. Ther. 306, 821-827 10.1124/jpet.102.041616
22. Hasselmo, M. E. and Sarter, M. (2011) Modes and models of forebrain cholinergic neuromodulation of cognition Neuropsychopharmacology 36, 52-73 10.1038/npp.2010.104
23. Jones, C. K., Byun, N., and Bubser, M. (2012) Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia Neuropsychopharmacology 37, 16-42 10.1038/npp.2011.199
24. Bubser, M., Byun, N., Wood, M. R., and Jones, C. K. (2012) Muscarinic receptor pharmacology and circuitry for the modulation of cognition Handb Exp Pharmacol 121-166 10.1007/978-3-642-23274-9
25. Carruthers, S. P., Gurvich, C. T., and Rossell, S. L. (2015) The muscarinic system, cognition and schizophrenia Neurosci. Biobehav. Rev. 55, 393-402 10.1016/j.neubiorev.2015.05.011
26. Dean, B., McLeod, M., Keriakous, D., McKenzie, J., and Scarr, E. (2002) Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia Mol. Psychiatry 7, 1083-1091 10.1038/sj.mp.4001199
27. Gibbons, A. S., Scarr, E., Boer, S., Money, T., Jeon, W. J., Felder, C., and Dean, B. (2013) Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia Int. J. Neuropsychopharmacol. 16, 37-46 10.1017/S1461145712000028
28. Scarr, E., Craig, J. M., Cairns, M. J., Seo, M. S., Galati, J. C., Beveridge, N. J., Gibbons, A., Juzva, S., Weinrich, B., Parkinson-Bates, M., Carroll, A. P., Saffery, R., and Dean, B. (2013) Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA Transl. Psychiatry 3, e230 10.1038/tp.2013.3
29. Shirey, J. K., Brady, A. E., Jones, P. J., Davis, A. A., Bridges, T. M., Kennedy, J. P., Jadhav, S. B., Menon, U. N., Xiang, Z., Watson, M. L., Christian, E. P., Doherty, J. J., Quirk, M. C., Snyder, D. H., Lah, J. J., Levey, A. I., Nicolle, M. M., Lindsley, C. W., and Conn, P. J. (2009) A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning J. Neurosci. 29, 14271-14286 10.1523/JNEUROSCI.3930-09.2009
30. Marino, M. J. and Conn, P. J. (2002) Direct and indirect modulation of the N-methyl D-aspartate receptor Curr. Drug Targets: CNS Neurol. Disord. 1, 1-16 10.2174/1568007023339544
31. Marino, M. J., Rouse, S. T., Levey, A. I., Potter, L. T., and Conn, P. J. (1998) Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells Proc. Natl. Acad. Sci. U. S. A. 95, 11465-11470 10.1073/pnas.95.19.11465
32. Lynch, D. R. and Guttmann, R. P. (2002) Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypes J. Pharmacol. Exp. Ther. 300, 717-723 10.1124/jpet.300.3.717
33. Ma, L., Seager, M. A., Wittmann, M., Jacobson, M., Bickel, D., Burno, M., Jones, K., Graufelds, V. K., Xu, G., Pearson, M., McCampbell, A., Gaspar, R., Shughrue, P., Danziger, A., Regan, C., Flick, R., Pascarella, D., Garson, S., Doran, S., Kreatsoulas, C., Veng, L., Lindsley, C. W., Shipe, W., Kuduk, S., Sur, C., Kinney, G., Seabrook, G. R., and Ray, W. J. (2009) Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation Proc. Natl. Acad. Sci. U. S. A. 106, 15950-15955 10.1073/pnas.0900903106
34. Chambon, C., Jatzke, C., Wegener, N., Gravius, A., and Danysz, W. (2012) Using cholinergic M1 receptor positive allosteric modulators to improve memory via enhancement of brain cholinergic communication Eur. J. Pharmacol. 697, 73-80 10.1016/j.ejphar.2012.10.011
35. Chambon, C., Wegener, N., Gravius, A., and Danysz, W. (2011) A new automated method to assess the rat recognition memory: validation of the method Behav. Brain Res. 222, 151-157 10.1016/j.bbr.2011.03.032
36. Digby, G. J., Noetzel, M. J., Bubser, M., Utley, T. J., Walker, A. G., Byun, N. E., Lebois, E. P., Xiang, Z., Sheffler, D. J., Cho, H. P., Davis, A. A., Nemirovsky, N. E., Mennenga, S. E., Camp, B. W., Bimonte-Nelson, H. A., Bode, J., Italiano, K., Morrison, R., Daniels, J. S., Niswender, C. M., Olive, M. F., Lindsley, C. W., Jones, C. K., and Conn, P. J. (2012) Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models J. Neurosci. 32, 8532-8544 10.1523/JNEUROSCI.0337-12.2012
37. Galloway, C. R., Lebois, E. P., Shagarabi, S. L., Hernandez, N. A., and Manns, J. R. (2014) Effects of selective activation of M1 and M4 muscarinic receptors on object recognition memory performance in rats Pharmacology 93, 57-64 10.1159/000357682
38. Uslaner, J. M., Eddins, D., Puri, V., Cannon, C. E., Sutcliffe, J., Chew, C. S., Pearson, M., Vivian, J. A., Chang, R. K., Ray, W. J., Kuduk, S. D., and Wittmann, M. (2013) The muscarinic M1 receptor positive allosteric modulator PQCA improves cognitive measures in rat, cynomolgus macaque, and rhesus macaque Psychopharmacology (Berl) 225, 21-30 10.1007/s00213-012-2788-8
39. Ghoshal, A., Rook, J. M., Dickerson, J. W., Roop, G. N., Morrison, R. D., Jalan-Sakrikar, N., Lamsal, A., Noetzel, M. J., Poslusney, M. S., Wood, M. R., Melancon, B. J., Stauffer, S. R., Xiang, Z., Daniels, J. S., Niswender, C. M., Jones, C. K., Lindsley, C. W., and Conn, P. J. (2015) Potentiation of M Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model Neuropsychopharmacology 10.1038/npp.2015.189
40. Shekhar, A., Potter, W. Z., Lightfoot, J., Lienemann, J., Dube, S., Mallinckrodt, C., Bymaster, F. P., McKinzie, D. L., and Felder, C. C. (2008) Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia Am. J. Psychiatry 165, 1033-1039 10.1176/appi.ajp.2008.06091591
41. Bartko, S. J., Romberg, C., White, B., Wess, J., Bussey, T. J., and Saksida, L. M. (2011) Intact attentional processing but abnormal responding in M1 muscarinic receptor-deficient mice using an automated touchscreen method Neuropharmacology 61, 1366-1378 10.1016/j.neuropharm.2011.08.023
42. Ragozzino, M. E., Artis, S., Singh, A., Twose, T. M., Beck, J. E., and Messer, W. S., Jr. (2012) The selective M1 muscarinic cholinergic agonist CDD-0102A enhances working memory and cognitive flexibility J. Pharmacol. Exp. Ther. 340, 588-594 10.1124/jpet.111.187625
43. Morton, A. J., Skillings, E., Bussey, T. J., and Saksida, L. M. (2006) Measuring cognitive deficits in disabled mice using an automated interactive touchscreen system Nat. Methods 3, 767 10.1038/nmeth1006-767
44. Jazbec, S., Pantelis, C., Robbins, T., Weickert, T., Weinberger, D. R., and Goldberg, T. E. (2007) Intra-dimensional/extra-dimensional set-shifting performance in schizophrenia: impact of distractors Schizophr Res. 89, 339-349 10.1016/j.schres.2006.08.014
45. Nagahara, A. H., Bernot, T., and Tuszynski, M. H. (2010) Age-related cognitive deficits in rhesus monkeys mirror human deficits on an automated test battery Neurobiol. Aging 31, 1020-1031 10.1016/j.neurobiolaging.2008.07.007
46. Miyakawa, T., Yamada, M., Duttaroy, A., and Wess, J. (2001) Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor J. Neurosci. 21, 5239-5250
47. Anagnostaras, S. G., Murphy, G. G., Hamilton, S. E., Mitchell, S. L., Rahnama, N. P., Nathanson, N. M., and Silva, A. J. (2002) Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice Nat. Neurosci. 6, 51-58 10.1038/nn992
48. Comte, M., Schon, D., Coull, J. T., Reynaud, E., Khalfa, S., Belzeaux, R., Ibrahim, E. C., Guedj, E., Blin, O., Weinberger, D. R., and Fakra, E. (2014) Dissociating Bottom-Up and Top-Down Mechanisms in the Cortico-Limbic System during Emotion Processing Cereb Cortex. 10.1093/cercor/bhu185
49. Waskom, M. L., Kumaran, D., Gordon, A. M., Rissman, J., and Wagner, A. D. (2014) Frontoparietal representations of task context support the flexible control of goal-directed cognition J. Neurosci. 34, 10743-10755 10.1523/JNEUROSCI.5282-13.2014
50. Canals, M., Lane, J. R., Wen, A., Scammells, P. J., Sexton, P. M., and Christopoulos, A. (2012) A Monod-Wyman-Changeux mechanism can explain G protein-coupled receptor (GPCR) allosteric modulation J. Biol. Chem. 287, 650-659 10.1074/jbc.M111.314278
51. Wood, S., Sage, J. R., Shuman, T., and Anagnostaras, S. G. (2013) Psychostimulants and cognition: a continuum of behavioral and cognitive activation Pharmacol. Rev. 66, 193-221 10.1124/pr.112.007054
52. Arnsten, A. F. (2011) Catecholamine influences on dorsolateral prefrontal cortical networks Biol. Psychiatry 69, e89-99 10.1016/j.biopsych.2011.01.027
53. Conn, P. J., Jones, C. K., and Lindsley, C. W. (2009) Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders Trends Pharmacol. Sci. 30, 148-155 10.1016/j.tips.2008.12.002
54. Davie, B. J., Christopoulos, A., and Scammells, P. J. (2013) Development of M1 mAChR allosteric and bitopic ligands: prospective therapeutics for the treatment of cognitive deficits ACS Chem. Neurosci. 4, 1026-1048 10.1021/cn400086m
55. van Koppen, C. J. and Kaiser, B. (2003) Regulation of muscarinic acetylcholine receptor signaling Pharmacol. Ther. 98, 197-220 10.1016/S0163-7258(03)00032-9
56. Markram, H. and Segal, M. (1990) Long-lasting facilitation of excitatory postsynaptic potentials in the rat hippocampus by acetylcholine J. Physiol. 427, 381-393 10.1113/jphysiol.1990.sp018177
57. Zhang, X. L., Sullivan, J. A., Moskal, J. R., and Stanton, P. K. (2008) A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral-CA1 synapses in hippocampus Neuropharmacology 55, 1238-1250 10.1016/j.neuropharm.2008.08.018
58. Zhao, M. G., Toyoda, H., Lee, Y. S., Wu, L. J., Ko, S. W., Zhang, X. H., Jia, Y., Shum, F., Xu, H., Li, B. M., Kaang, B. K., and Zhuo, M. (2005) Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory Neuron 47, 859-872 10.1016/j.neuron.2005.08.014
59. Brigman, J. L., Feyder, M., Saksida, L. M., Bussey, T. J., Mishina, M., and Holmes, A. (2008) Impaired discrimination learning in mice lacking the NMDA receptor NR2A subunit Learn. Mem. 15, 50-54 10.1101/lm.777308
60. Darvas, M. and Palmiter, R. D. (2015) Specific contributions of N-methyl-d-aspartate receptors in the dorsal striatum to cognitive flexibility Neuroscience 284, 934-942 10.1016/j.neuroscience.2014.11.011
61. Bubser, M., Bridges, T. M., Dencker, D., Gould, R. W., Grannan, M., Noetzel, M. J., Lamsal, A., Niswender, C. M., Daniels, J. S., Poslusney, M. S., Melancon, B. J., Tarr, J. C., Byers, F. W., Wess, J., Duggan, M. E., Dunlop, J., Wood, M. W., Brandon, N. J., Wood, M. R., Lindsley, C. W., Conn, P. J., and Jones, C. K. (2014) Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents ACS Chem. Neurosci. 5, 920-942 10.1021/cn500128b
62. Talpos, J. C., Fletcher, A. C., Circelli, C., Tricklebank, M. D., and Dix, S. L. (2012) The pharmacological sensitivity of a touchscreen-based visual discrimination task in the rat using simple and perceptually challenging stimuli Psychopharmacology (Berl) 221, 437-449 10.1007/s00213-011-2590-z
63. Coyle, J. T., Basu, A., Benneyworth, M., Balu, D., and Konopaske, G. (2012) Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications Handb Exp Pharmacol 267-295 10.1007/978-3-642-25758-2
64. Tsai, G. and Coyle, J. T. (2002) Glutamatergic mechanisms in schizophrenia Annu. Rev. Pharmacol. Toxicol. 42, 165-179 10.1146/annurev.pharmtox.42.082701.160735
65. Di, L., Umland, J. P., Chang, G., Huang, Y., Lin, Z., Scott, D. O., Troutman, M. D., and Liston, T. E. (2011) Species independence in brain tissue binding using brain homogenates Drug Metab. Dispos. 39, 1270-1277 10.1124/dmd.111.038778
66. Richardson, N. R. and Roberts, D. C. (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy J. Neurosci. Methods 66, 1-11 10.1016/0165-0270(95)00153-0